Talk to us
Explore what is possible with ImmuNovus
We are looking for select early-adoption partners to co-design the next questions, implement and analyze the technology, and supply strategic feedback.
What you can ask
- Which targets and indications to pursue
- How a mechanism of action plays out across scales
- Which biomarkers may distinguish responders from non-responders
- Which treatments to prioritize, and in what order
- Which existing compounds may be worth repurposing
- Where a candidate is likely to fail, before the next cycle is funded